Cost analysis of treating cardiovascular diseases in a super-specialty hospital
- PMID: 34986193
- PMCID: PMC8730466
- DOI: 10.1371/journal.pone.0262190
Cost analysis of treating cardiovascular diseases in a super-specialty hospital
Abstract
Cardiovascular care is expensive; hence, economic evaluation is required to estimate resources being consumed and to ensure their optimal utilization. There is dearth of data regarding cost analysis of treating various diseases including cardiac diseases from developing countries. The study aimed to analyze resource consumption in treating cardio-vascular disease patients in a super-specialty hospital. An observational and descriptive study was carried out from April 2017 to June 2018 in the Department of Cardiology, Cardio-Thoracic (CT) Centre of All India Institute of Medical Sciences, New Delhi, India. As per World Health Organization, common cardiovascular diseases i.e. Coronary Artery Disease (CAD), Rheumatic Heart Disease (RHD), Cardiomyopathy, Congenital heart diseases, Cardiac Arrhythmias etc. were considered for cost analysis. Medical records of 100 admitted patients (Ward & Cardiac Care Unit) of cardiovascular diseases were studied till discharge and number of patient records for a particular CVD was identified using prevalence-based ratio of admitted CVD patient data. Traditional Costing and Time Driven Activity Based Costing (TDABC) methods were used for cost computation. Per bed per day cost incurred by the hospital for admitted patients in Cardiac Care Unit, adult and pediatric cardiology ward was calculated to be Indian Rupee (INR) 28,144 (US$ 434), INR 22,210 (US$ 342) and INR 18,774 (US$ 289), respectively. Inpatient cost constituted almost 70% of the total cost and equipment cost accounted for more than 50% of the inpatient cost followed by human resource cost (28%). Per patient cost of treating any CVD was computed to be INR 2,47,822 (US $ 3842). Cost of treating Rheumatic Heart Disease was the highest among all CVDs followed by Cardiomyopathy and other CVDs. Cost of treating cardiovascular diseases in India is less than what has been reported in developed countries. Findings of this study would aid policy makers considering recent radical changes and massive policy reforms ushered in by the Government of India in healthcare delivery.
Conflict of interest statement
None declared.
Figures
References
-
- World Health Organisation (WHO). Cardiovascular diseases (CVDs). 17 May. 2017. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases...: Last accessed on 20.04.2021.
-
- World Health Organization (WHO). Non communicable Diseases Country Profiles. Genève: WHO Press, 2014. 2014;1–210. Accessible from: https://www.who.int/nmh/publications/ncd-profiles-2014/en/: Last accessed on 20.04.2021.
-
- India State-Level Disease Burden Initiative CVD Collaborators. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health. 2018. Dec;6(12):e1339–e1351. doi: 10.1016/S2214-109X(18)30407-8 Epub 2018 Sep 12. ; PMCID: PMC6227386. - DOI - PMC - PubMed
-
- American Heart Association. Cardiovascular disease: A costly burden for America—Projections through 2035. American Heart Association. 2017;7.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
